Epigenomics AG (FRA:ECX)

Market Cap	767.35K -10.7%
Revenue (ttm)	24.00K
Net Income	-314.00K
EPS	-0.36
Shares Out	876.98K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	0.8700
Previous Close	0.8700
Day's Range	0.8700 - 0.8700
52-Week Range	0.5000 - 1.5900
Beta	0.89
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 3
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ECX